Impact of Adjuvant Chemotherapy (ac) on Relapse-Free Survival (rfs) is Different According to Post-Chemoradiation Pathologic Stage (ypstage) in Rectal Cancer

S.Y. Kim,J.Y. Baek,E.K. Shim, H.M. Kim, M.S.I. Chang,J.Y. Ku, M.J. Kim,S.C. Park, D.Y. Kim,H.J. Chang,J.H. Oh

Annals of oncology（2014）

引用 0|浏览13

暂无评分

摘要

Aim: In contrast with colon cancer, survival benefit from adjuvant chemotherapy (AC) in rectal cancer is still unclear. For patients (pts) who are treated with preoperative chemoradiation (preop CRT), post-chemoradiation pathologic stage (ypStage) is known to be a major determinant of long term outcome. We aimed to describe clinical benefit from AC in terms of relapse-free survival (RFS) according to ypStage in rectal cancer.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要